Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Denis Maillet

Showing results (21-30 of 70) with videos related to

Pageof 7
Sort By:
The French Journal of Urology|June 23, 2025
Predicting recurrence and progression in NMIBC: A multi-event and temporal analysis approachHugo Brouzes, Said Ourfali, Hakim Fassi-Fehri, et al.
Bulletin Du Cancer|March 24, 2020
[Checkpoint inhibitors-induced hypophysitis]Juliette Abeillon du Payrat, Christine Cugnet-Anceau, Denis Maillet, et al.
European Journal of Cancer (Oxford, England : 1990)|October 8, 2019
Older and younger patients treated with immune checkpoint inhibitors have similar outcomes in real-life settingPauline Corbaux, Denis Maillet, Amélie Boespflug, et al.
Cancers|December 10, 2021
Her2 Expression in Circulating Tumor Cells Is Associated with Poor Outcomes in Patients with Metastatic Castration-Resistant Prostate CancerDenis Maillet, Nathalie Allioli, Julien Péron, et al.
Biomedicines|January 21, 2023
Impact of Liver Metastases and Number of Metastatic Sites on Immune-Checkpoint Inhibitors Efficacy in Patients with Different Solid Tumors: A Retrospective StudyMadeleine Maugeais, Julien Péron, Stéphane Dalle, et al.
Bulletin Du Cancer|June 23, 2022
[Metastatic renal cell carcinoma: Management of toxicities of combinations]Florence Joly, Jean-Marie Michot, Louis Marie Dourthe, et al.
European Journal of Cancer (Oxford, England : 1990)|April 26, 2020
Association between immune-related adverse events and long-term survival outcomes in patients treated with immune checkpoint inhibitorsDenis Maillet, Pauline Corbaux, Jean-Jacques Stelmes, et al.
The Oncologist|October 17, 2019
Guillain-Barré Syndrome During Platinum-Based Chemotherapy: A Case Series and Review of the LiteratureEvangelia Pappa, Giulia Berzero, Bastien Herlin, et al.
Bulletin Du Cancer|April 27, 2021
[Rheumatic immune adverse events related to immune checkpoint inhibitors-(IrAEs related to ICI)]Thomas Tingry, Emmanuel Massy, Muriel Piperno, et al.
Human Pathology|May 18, 2016
Genomic copy number alterations in 33 malignant peritoneal mesothelioma analyzed by comparative genomic hybridization arrayPierre Chirac, Denis Maillet, Frédéric Leprêtre, et al.
Pageof 7

Showing results (21-30 of 70) with videos related to

Sort By:
Pageof 7
The French Journal of Urology|June 23, 2025
Predicting recurrence and progression in NMIBC: A multi-event and temporal analysis approachHugo Brouzes, Said Ourfali, Hakim Fassi-Fehri, et al.
Bulletin Du Cancer|March 24, 2020
[Checkpoint inhibitors-induced hypophysitis]Juliette Abeillon du Payrat, Christine Cugnet-Anceau, Denis Maillet, et al.
European Journal of Cancer (Oxford, England : 1990)|October 8, 2019
Older and younger patients treated with immune checkpoint inhibitors have similar outcomes in real-life settingPauline Corbaux, Denis Maillet, Amélie Boespflug, et al.
Cancers|December 10, 2021
Her2 Expression in Circulating Tumor Cells Is Associated with Poor Outcomes in Patients with Metastatic Castration-Resistant Prostate CancerDenis Maillet, Nathalie Allioli, Julien Péron, et al.
Biomedicines|January 21, 2023
Impact of Liver Metastases and Number of Metastatic Sites on Immune-Checkpoint Inhibitors Efficacy in Patients with Different Solid Tumors: A Retrospective StudyMadeleine Maugeais, Julien Péron, Stéphane Dalle, et al.
Bulletin Du Cancer|June 23, 2022
[Metastatic renal cell carcinoma: Management of toxicities of combinations]Florence Joly, Jean-Marie Michot, Louis Marie Dourthe, et al.
European Journal of Cancer (Oxford, England : 1990)|April 26, 2020
Association between immune-related adverse events and long-term survival outcomes in patients treated with immune checkpoint inhibitorsDenis Maillet, Pauline Corbaux, Jean-Jacques Stelmes, et al.
The Oncologist|October 17, 2019
Guillain-Barré Syndrome During Platinum-Based Chemotherapy: A Case Series and Review of the LiteratureEvangelia Pappa, Giulia Berzero, Bastien Herlin, et al.
Bulletin Du Cancer|April 27, 2021
[Rheumatic immune adverse events related to immune checkpoint inhibitors-(IrAEs related to ICI)]Thomas Tingry, Emmanuel Massy, Muriel Piperno, et al.
Human Pathology|May 18, 2016
Genomic copy number alterations in 33 malignant peritoneal mesothelioma analyzed by comparative genomic hybridization arrayPierre Chirac, Denis Maillet, Frédéric Leprêtre, et al.
Pageof 7